Loading...
NPI 1508911728 · Newark, DE · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Minimally Invasive Surgical And Neuroscience LLC is a ambulatory surgical clinic/center provider located in Newark, Delaware. This profile covers 43 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Minimally Invasive Surgical And Neuroscience LLC |
| Address | 774 Christiana Rd |
| City | Newark |
| State | DE |
| ZIP | 19713 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | January 25, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2M |
| Medicaid | $108.3K |
MINIMALLY INVASIVE SURGICAL AND NEUROSCIENCE LLC presents as an ambulatory surgical clinic that bills a mix of implantable-device, brachytherapy, and endoscopic procedures, consistent with its Ambulatory Surgical Clinic/Center taxonomy; its top Medicare revenue drivers include C2641 (brachytherapy source), C9740 (cystourethroscopy with transprostatic implant), and 64590 (neurostimulator pulse generator insertion), indicating capability for radiation seed procedures, transprostatic implants, and surgical device implantation. This code mix suggests the facility operates specialized procedural suites able to support oncology-related brachytherapy, advanced urologic prosthetic procedures, and neuromodulation device work.
Medicare revenue is the dominant financial stream for the practice: total Medicare revenue on file is $2M and the platform’s precomputed measure shows the top 3 Medicare codes by revenue account for 36.3% of that Medicare revenue, pointing to material concentration in a handful of high-revenue services. The reliance on these top three codes means fluctuations in implantable-device or brachytherapy volumes would disproportionately affect overall Medicare receipts.
The Medicaid footprint is small and highly concentrated: total Medicaid revenue is $108.3K and the precomputed top-3 share is 100.0%, with two injection codes driving nearly all Medicaid receipts—64483 (67.8% of Medicaid revenue) and 64493 (32.2% of Medicaid revenue). This indicates the provider’s Medicaid activity is effectively focused on spinal/paravertebral injections and related pain-management procedures rather than the broader surgical mix seen under Medicare.
In payer-mix terms the practice is Medicare-dominant: $2M in Medicare revenue versus $108.3K in Medicaid revenue implies Medicare activity is an order of magnitude larger and operational priorities and capital investment likely reflect the higher Medicare case mix and reimbursement scale. Medicaid appears to be a secondary line concentrated in outpatient injection services rather than a balanced dual-payer case mix.
Competitive standing varies by code: the practice ranks #1 of 7 nationally for C2641 (100th percentile) even as that code is annotated "typical, unremarkable volume," indicating leadership among a very small national cohort for that brachytherapy source; by contrast the provider is an "extreme outlier" for 50590 (ESWL) at rank #11 of 1163 (99th percentile), signaling unusually high lithotripsy volume relative to national peers and a possible regional specialization in stone-management services. These differences show the practice is a modest participant on many implant codes but markedly concentrated for a few specific procedural lines.
Multiple additional Medicare codes post above-typical national volumes across urology and ENT/endoscopic services—examples include 55875 (rank #3 of 122, 98th percentile, notably above typical), 52648 (92nd percentile), 52332 (94th percentile), 31276 (97th percentile), 31267 (98th percentile), and 31259 (97th percentile). Together these rankings support a regional specialty footprint that extends beyond implants and brachytherapy into high-volume urologic endoscopy and sinus surgery, suggesting referral flows for those service lines.
Operational billing characteristics reinforce the device- and implant-oriented profile: several high-average-paid-per-claim procedures appear in the Medicare top list, for example 64590 has an avg paid/claim of $15467 and C9740 has an avg paid/claim of $5774, which reflects cases with significant device or procedural supply costs and higher per-case reimbursement. Those high per-claim averages align with the facility’s role performing surgically complex, device-dependent interventions in an ambulatory setting.
The provider has established tenure in Medicare enrollment—NPI enumerated 2007-01-25 (~19 years ago)—and also records non-revenue quality/process Medicaid codes (G8907 and G8918 with $0 average paid), indicating routine submission of facility-level quality or process indicators to Medicaid despite minimal Medicaid revenue impact. Longevity combined with submitted quality codes suggests an operationally mature ambulatory surgical operation that maintains reporting on standard perioperative quality measures.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
43 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| C2641 | Brachytherapy source, non-stranded, palladium-103, per source | 3,560 | $60 | $228.1K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 40 | $5,770 | $225.2K |
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 10 | $15,470 | $216.5K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 180 | $880 | $161.4K |
| 50590 | Extracorporeal shock wave lithotripsy (ESWL) is a procedure used to destroy calculus (kidney stones) in the kidneys and ureters. | 130 | $1,140 | $146.4K |
| 55875 | The provider, a urologist or oncologist, places needles or catheters into the prostate for separate placement of radioactive "seeds" to treat prostate cancer; needle or catheter placement may be done… | 70 | $1,810 | $117.6K |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 20 | $3,990 | $95.9K |
| 52648 | Transurethral resection of the prostate is performed in cases of BPH (benign prostate hyperplasia) which commonly occurs in middle–aged and elderly men, often causing lower urinary symptoms, with… | 40 | $1,730 | $74.3K |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | 140 | $430 | $61.1K |
| 31276 | In this procedure, the provider inserts an endoscope into the frontal sinus to explore it for abnormalities. The provider may also remove bone, scar tissue, polyps, or other tissue from the frontal… | 50 | $1,320 | $60.9K |
Showing 1–10 of 43
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 43 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
43 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C2641 | 1 | 10 | 3,560 | $60 | $226.3K |
| C9740 | 1 | 10 | 40 | $5,770 | $225.2K |
| 66984 | 20 | 50 | 70 | $590 | $163.6K |
| 64590 | 1 | 10 | 10 | $8,370 | $108.8K |
| J0585 | 8 | 20 | 5,800 | $1 | $76.2K |
| 45385 | 30 | 60 | 100 | $310 | $44.7K |
| 64561 | 1 | 10 | 20 | $2,040 | $34.8K |
| 55875 | 1 | 10 | 10 | $1,260 | $29.1K |
| C2639 | 1 | 10 | 1,030 | $30 | $28.4K |
| 50590 | 1 | 20 | 30 | $760 | $26.5K |
Showing 1–10 of 43
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 280 | $270 | $73.4K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 160 | $220 | $34.8K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 80 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Delaware providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Delaware median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 7 | 10 | 340 | $140 | $79.7K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 3 | 10 | 150 | $60 | $35.8K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 6 | 10 | 150 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 4 | 10 | 50 | $0 | $0 |
Other providers in the same ZIP code as Minimally Invasive Surgical And Neuroscience LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.